angiotensin ii, des-phe(8)- has been researched along with Muscular Dystrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chapleau, MW; Cicha, MZ; De Sousa, FB; Sabharwal, R; Santos, RA; Sinisterra, RD | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and Muscular Dystrophy
Article | Year |
---|---|
Chronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy.
Topics: Administration, Oral; Angiotensin I; Animals; Dystrophin; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Muscle, Skeletal; Muscular Dystrophies; Peptide Fragments; Phenotype; Sarcoglycans | 2014 |